Dasami Lab Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PIMAVANSERIN TARTRATE, with a corresponding US DMF Number 34354.
Remarkably, this DMF maintains an Active status since its submission on February 04, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 20, 2020, and payment made on January 27, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II